Literature DB >> 2452492

Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients.

D S Holloway1, L Summaria, J Sandesara, J P Vagher, J C Alexander, J A Caprini.   

Abstract

We simultaneously evaluated platelet and fibrinolytic parameters to assess their individual and combined contributions to postoperative blood loss in cardiopulmonary (CP) bypass patients. Platelet count, platelet aggregability, hematocrit, plasminogen (PLG) concentration, alpha 2-antiplasmin (AP) concentration, free protease activity (fPA), and antithrombin-III (AT-III) were measured in nine patients undergoing surgery using cardiopulmonary bypass. Chest tube drainage was used as the measure of postoperative blood loss. Hematocrit, platelet count, PLG, AP, and AT-III all decreased during CP bypass, with PLG and AT-III decreasing much more than dilution. During CP bypass, platelet aggregability to ADP did not change significantly from pre-bypass, but aggregability to arachidonic acid (AA) decreased significantly. Following protamine administration there was a large increase (83%) in fPA, the platelet count showed a further drop (from 61% to 50% of pre-bypass levels), and platelet aggregability decreased significantly (from 95% to 34% of pre-bypass levels for ADP, and from 55% to 11.9% for AA). Chest tube drainage during the first four postoperative hours correlated positively (p less than 0.05) with the combination of increase in free protease activity and decrease in platelet count. The total chest tube drainage correlated significantly with the combination of decrease in platelet count and the decrease in platelet aggregability. These combinations of changes correlated significantly with postoperative blood loss whereas the individual changes did not.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452492

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  19 in total

1.  Phosphodiesterase-inhibitors enoximone and piroximone in cardiac surgery: influence on platelet count and function.

Authors:  J Boldt; C Knothe; B Zickmann; C Herold; E Dapper; G Hempelmann
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 2.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

3.  Use of the Hemobag for modified ultrafiltration in a Jehovah's Witness patient undergoing cardiac surgery.

Authors:  David M Moskowitz; James J Klein; Aryeh Shander; Seth I Perelman; Kirk A McMurtry; Katherine M Cousineau; M Arisan Ergin
Journal:  J Extra Corpor Technol       Date:  2006-09

4.  Antiplatelet drugs: mechanisms and risks of bleeding following cardiac operations.

Authors:  Victor A Ferraris; Suellen P Ferraris; Sibu P Saha
Journal:  Int J Angiol       Date:  2011-03

Review 5.  Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-01-23       Impact factor: 2.300

Review 6.  Antifibrinolytic therapy in cardiac surgery.

Authors:  R H Chen; O H Frazier; D A Cooley
Journal:  Tex Heart Inst J       Date:  1995

7.  Centrifugal and roller pumps--are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?

Authors:  B E Steinbrueckner; U Steigerwald; F Keller; K Neukam; O Elert; J Babin-Ebell
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

Review 8.  Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.

Authors:  R Davis; R Whittington
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

9.  Does platelet size correlate with function in patients undergoing cardiac surgery?

Authors:  J Boldt; B Zickmann; M Benson; F Dapper; G Hempelmann; E Schindler
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

10.  Effects of aprotinin on hemorrhagic complications in ARDS patients during prolonged extracorporeal CO2 removal.

Authors:  F Brunet; J P Mira; M Belghith; J J Lanore; S Schlumberger; P Toulon; J F Dhainaut
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.